From the Office of Senator Welch:
On Wednesday, September 6, Senator Peter Welch (D-Vt.) joins Families USA and Patients for Affordable Drugs for a virtual press conference to break down and discuss the future impact and implications for the Biden administration’s recent announcement of the first ten drugs selected for Medicare price negotiation - a vital component of the Inflation Reduction Act (IRA). Experts are available to answer questions or provide context.
Senator Welch, a critical voice on drug price reforms, was a champion of the IRA when he voted for it in the House of Representatives. As a Senator, he has led legislation to build on the success of the IRA and empower HHS to negotiate for even more prescription drugs in Medicare Part D. He discusses why this is a crucial inflection point for Congress: to see the law implemented as intended, and to protect families whose health and wallets have hung in the balance for far too long - mainly because big drug companies are putting profits before people’s health.
Speakers include Senator Peter Welch (D-VT); Jen Taylor, Senior Director of Federal Relations, Families USA; and David Mitchell, Cancer Patient and Founder, Patients For Affordable Drugs Now.
